For help on how to get the results you want, see our search tips.
64 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Referral status
European Commission final decision Remove European Commission final decision filter
Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter
Referral type
Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter
Article 35 Remove Article 35 filter
Article 13 referrals Remove Article 13 referrals filter
Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter
Articles 39 and 40 Remove Articles 39 and 40 filter
-
List item
Referral: Suvaxyn Parvo/E
Articles 39 and 40
Status: European Commission final decision, opinion/position date: 17/01/2007, EC decision date: 17/04/2007, Last updated: 15/11/2007 -
List item
Referral: Suvaxyn Ery
Articles 39 and 40
Status: European Commission final decision, opinion/position date: 17/01/2007, EC decision date: 19/04/2007, Last updated: 15/11/2007 -
List item
Referral: All pre-mixes for medicated feedingstuff containing 40 g, 100 g or 200 g tilmicosin per kg pre-mix and administered to rabbits
tilmicosin, associated names: See annex I, Article 35
Status: European Commission final decision, opinion/position date: 07/03/2012, EC decision date: 14/06/2012, Last updated: 19/07/2012 -
List item
Referral: Basiron AC and associated names
benzoyl peroxide, Article 13 referrals
Status: European Commission final decision, opinion/position date: 28/03/2019, EC decision date: 04/07/2019, Last updated: 19/07/2019 -
List item
Referral: Baytril injectable and generics
enrofloxacin, Article 35
Status: European Commission final decision, opinion/position date: 09/04/2014, EC decision date: 01/09/2014, Last updated: 10/12/2014 -
List item
Referral: Benzathine benzylpenicillin intended for administration to food-producing species
benzathine benzylpenicillin, associated names: See annex I, Article 35
Status: European Commission final decision, opinion/position date: 15/01/2003, EC decision date: 22/04/2003, Last updated: 26/07/2016 -
List item
Referral: Betamox LA 150 mg/ml suspension for injection and associated names, and generics products thereof
Amoxicillin trihydrate, Article 35
Status: European Commission final decision, opinion/position date: 16/07/2020, EC decision date: 12/10/2020, Last updated: 12/11/2020 -
List item
Referral: Bupropion hydrochloride
bupropion, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 25/07/2002, EC decision date: 25/10/2002, Last updated: 06/12/2002 -
List item
Referral: Cardioxane
dexrazoxane, Article 13 referrals
Status: European Commission final decision, opinion/position date: 19/07/2017, EC decision date: 19/07/2017, Last updated: 26/07/2017 -
List item
Referral: Cephalosporins
ceftiofur and cefquinome, associated names: Cobactan, Cefenil, Ceftiocyl, Cevaxel, Eficur, Excenel, Readycef, Virbacef, Truleva, Ceftiomax, Ceftiosan, Actionis, Cemay, Article 35
Status: European Commission final decision, opinion/position date: 13/10/2011, EC decision date: 13/01/2012, Last updated: 01/02/2012 -
List item
Referral: Cerivastatin
cerivastatin, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 21/03/2002, EC decision date: 22/08/2002, Last updated: 20/12/2002 -
List item
Referral: Closantel
closantel, Article 35
Status: European Commission final decision, opinion/position date: 21/02/2019, EC decision date: 20/05/2019, Last updated: 27/06/2019 -
List item
Referral: Colistin
Colistin sulfate, Article 35
Status: European Commission final decision, opinion/position date: 10/02/2010, EC decision date: 10/06/2010, Last updated: 24/06/2010 -
List item
Referral: Colistin oral
colistin, Article 35
Status: European Commission final decision, opinion/position date: 11/12/2014, EC decision date: 16/03/2015, Last updated: 13/04/2015 -
List item
Referral: Dexadreson
dexamethasone, Article 35
Status: European Commission final decision, opinion/position date: 18/07/2013, EC decision date: 18/10/2013, Last updated: 27/11/2013 -
List item
Referral: Dinolytic 12.5 mg/ml and 5 mg/ml solutions for injection and associated names, and generic products thereof
Dinoprost, Article 35
Status: European Commission final decision, opinion/position date: 18/06/2020, EC decision date: 16/09/2020, Last updated: 06/10/2020 -
List item
Referral: Doramectin
doramectin, Article 35
Status: European Commission final decision, opinion/position date: 12/06/2013, EC decision date: 06/09/2013, Last updated: 18/10/2013 -
List item
Referral: Doxycycline hyclate
Doxycycline hyclate, Article 35
Status: European Commission final decision, opinion/position date: 11/02/2010, EC decision date: 14/06/2010, Last updated: 28/06/2011 -
List item
Referral: Flukicides for which no maximum residue limit has been established in milk and which are intended for use in ruminants producing milk for human consumption
clorsulon, closantel, nitroxinil, rafoxanide, triclabendazole, Article 35
Status: European Commission final decision, opinion/position date: 14/06/2012, EC decision date: 19/11/2012, Last updated: 18/01/2013 -
List item
Referral: Gadograf, Gadovist
gadobutrol, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 17/11/2006, EC decision date: 13/04/2007, Last updated: 09/11/2007 -
List item
Referral: Gentamicin
gentamicin, Article 35
Status: European Commission final decision, opinion/position date: 06/11/2014, EC decision date: 11/02/2015, Last updated: 10/04/2015 -
List item
Referral: Goserelin Cell Pharm
goserelin, associated names: Novosis Goserelin, Goserelin Cell Pharm, Novimp and associated names, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 16/09/2011, Last updated: 06/02/2012 -
List item
Referral: Hipralona Enro-S
enrofloxacin, Article 35
Status: European Commission final decision, opinion/position date: 13/09/2012, EC decision date: 17/12/2012, Last updated: 04/02/2013 -
List item
Referral: Ivermectin
Ivermectin, Article 35
Status: European Commission final decision, opinion/position date: 05/06/2009, EC decision date: 01/10/2009, Last updated: 26/10/2009 -
List item
Referral: Kantos Master
beclomethasone dipropionate / formoterol fumarate, associated names: Kantos, Formodual, Foster, Inuxair, Innovair and associated names, Article 13 referrals
Status: European Commission final decision, opinion/position date: 17/01/2013, EC decision date: 10/04/2013, Last updated: 02/05/2013